✨ DEI in #hematology is one of Dr Eleni Gavriilaki's great passions. 💖 Join her and host Dr Sarah de Vlieger as they discuss current DEI challenges and how organizations like EHA are addressing them. 🎧 Listen on major podcast platforms or #EHACampus:
European Hematology Association (EHA)’s Post
More Relevant Posts
-
Over the past two years, #EHA has worked hard to address the needs of the European #hematology community. We would now like to celebrate the impressive results of our collective hard work with nearly 8,000 members from 152+ countries. Read more about what we have achieved together online: https://eha.fyi/Bridging
To view or add a comment, sign in
-
Welcome to a #LearningMondays Morphology Challenge! Today's question is by Dr Veysel Erol. Determine the least probable diagnosis. ✏️ Submit your answer and receive immediate feedback in our form: https://lnkd.in/eFpDgHN4 📆 Or come back tomorrow for the answer & explanation.
To view or add a comment, sign in
-
Join EHA and Keith Flaherty at the EHA-SfPM Precision Medicine Meeting! The meeting unites genomic and functional precision medicine and brings together experts from multiple fields. Register here:
EHA-SfPM Precision Medicine Meeting
ehaweb.org
To view or add a comment, sign in
-
Does your project potentially have a high impact but lacks preliminary proof-of-concept data for larger funding opportunities? Make sure to apply to the #EHA Kick-off Grant, offering: 👉 €50,000 for one year 👉 Specific focus on #hematologyresearch 👉 Open to post-docs and MDs. PhDs in their final years who are going to be enrolled in a postdoc are also encouraged to apply. Apply now: https://eha.fyi/KOG2025 Additional calls for #EHAGrants are also open. Browse more funding opportunities: https://eha.fyi/Grants2025
To view or add a comment, sign in
-
⏳ Final week of free full access to the #EHACampus! 📚 Until July 14, sign up as an EHA Guest and access over 250 hematology programs, courses, clinical cases, webinars, podcasts, flashcards, schemas, expert commentary, and algorithms. Find out more:
I would like to be an EHA Guest
ehaweb.org
To view or add a comment, sign in
-
🔬Discover our updated #CLL Pathophysiology course!🔬 Refreshed with new information, topics include genetic alterations, molecular pathways driving CLL leukemogenesis, and the use of molecular biomarkers for prognosis and treatment prediction. #leukemia
EHA Campus
ehacampus.ehaweb.org
To view or add a comment, sign in
-
There is one week left to apply for the #EHAMasterClass 2024/25, apply by July 15 for the chance to join our online clinical preceptorship. Under the guidance of two mentors, you will solve 5 challenging clinical cases, improve your practice, and connect with new professionals in #hematology. Apply now:
Master Class
ehaweb.org
To view or add a comment, sign in
-
👏👏 We would like to congratulate our #HemaSphere community of editors, authors, reviewers, and readership on the 2023 impact factor of 12.1. We look forward to even more quality publications and engagement. #EHA #hematology
Exciting news: our 2023 impact factor is 12.1! We are thankful for our editors, authors, reviewers, & readership. While this is 1 journal metric of many, it's an important milestone. We remain committed to high quality science + service. You can browse our #OpenAccess content at any time: www.hemaspherejournal.com Thank you, everyone, for your continued support.
To view or add a comment, sign in
-
This week's #learningMondays question was submitted by Dr Ufuk Demirci from the Edirne Sultan Murat 1. State Hospital in Turkey. ✏️ Submit your answer and receive feedback in our form: https://ehaedu.org/LM_71 📆 Or come back here tomorrow for the answer and explanation.
Fill | EHA Learning Mondays challenge July 8 2024
https://forms.office.com/pages/forms.office.com
To view or add a comment, sign in
-
View EU funding calls relevant to #hematology at a glance on the #EHA website. In order to help further our understanding of diseases and patient care, we collate funding calls to help our community achieve our advocacy priorities for personalized medicines, accessibility, and patient-centric unmet-needs-based therapy developments. Browse available calls: https://lnkd.in/eAkA4rX5
To view or add a comment, sign in